Stay up to date on COVID-19. Learn more
The Promise … and the Waiting: A New Era in Myeloma Treatment
October 26, 2026
When I think about the impact of new myeloma treatments, one word…
Myeloma Canada at the International Myeloma Society Annual Meeting 2026: Key Takeaways
October 26, 2026
Every year, leading myeloma researchers and advocates from around the world gather…
Defining Cure in Multiple Myeloma
October 26, 2026
Since it was first described in 1844, multiple myeloma has largely been…
The 2026 Multiple Myeloma March is Underway
September 24, 2026
From Newfoundland to British Columbia and everywhere in between, the 2026 Multiple Myeloma March…
September: A Time to Walk, Connect, and Be Heard!
September 23, 2026
September is Blood Cancer Awareness Month, a time to recognize everyone affected by…
Myeloma Canada Board of Directors Elects New Chair: Lorelei Dalrymple
August 19, 2026
This Spring, the Myeloma Canada Board of Directors elected Lorelei Dalrymple as Chair of…
Myeloma Canada’s Advocacy Handbook: Newly updated!
August 19, 2026
Myeloma Canada’s National Advocacy Committee is proud to announce the release of…
Building Credibility and Amplifying the Patient Voice
August 19, 2026
At Myeloma Canada, we often speak about the importance of ensuring that…
Key Takeaways from the Global Myeloma Action Network (GMAN) Summit
July 23, 2026
By Michelle Oana, Chief Mission Officer, Myeloma Canada Myeloma Canada was honoured to participate in the…
Taking It Step by Step: New Checklists for Transplant and the Road Ahead
July 23, 2026
Living with multiple myeloma can involve many decisions, treatments and life changes, but education…
The Multiple Myeloma March Is Just Around the Corner. See you at the Starting Line!
July 23, 2026
Summer has a way of bringing people together. We gather around backyard…
The Patient Voice: Measuring What Truly Matters
June 18, 2026
When we talk about progress in myeloma, we often focus on the…
The Promise … and the Waiting: A New Era in Myeloma Treatment
October 26, 2026
When I think about the impact of new myeloma treatments, one word…
The 2026 Multiple Myeloma March is Underway
September 24, 2026
From Newfoundland to British Columbia and everywhere in between, the 2026 Multiple Myeloma March…
September: A Time to Walk, Connect, and Be Heard!
September 23, 2026
September is Blood Cancer Awareness Month, a time to recognize everyone affected by…
Myeloma Canada Board of Directors Elects New Chair: Lorelei Dalrymple
August 19, 2026
This Spring, the Myeloma Canada Board of Directors elected Lorelei Dalrymple as Chair of…
Myeloma Canada’s Advocacy Handbook: Newly updated!
August 19, 2026
Myeloma Canada’s National Advocacy Committee is proud to announce the release of…
Building Credibility and Amplifying the Patient Voice
August 19, 2026
At Myeloma Canada, we often speak about the importance of ensuring that…
Key Takeaways from the Global Myeloma Action Network (GMAN) Summit
July 23, 2026
By Michelle Oana, Chief Mission Officer, Myeloma Canada Myeloma Canada was honoured to participate in the…
Taking It Step by Step: New Checklists for Transplant and the Road Ahead
July 23, 2026
Living with multiple myeloma can involve many decisions, treatments and life changes, but education…
The Multiple Myeloma March Is Just Around the Corner. See you at the Starting Line!
July 23, 2026
Summer has a way of bringing people together. We gather around backyard…
The Patient Voice: Measuring What Truly Matters
June 18, 2026
When we talk about progress in myeloma, we often focus on the…
The Myeloma Canada Ride: A Record-Breaking Cycling Season
June 18, 2026
This year’s Myeloma Canada Ride was nothing short of extraordinary. From coast…
5 Tips to Boost Your Myeloma Canada Ride Fundraising
May 21, 2026
Fundraising doesn’t have to feel overwhelming. Whether you’re a first-time rider or a seasoned cyclist, these…
The Promise … and the Waiting: A New Era in Myeloma Treatment
October 26, 2026
When I think about the impact of new myeloma treatments, one word…
Myeloma Canada at the International Myeloma Society Annual Meeting 2026: Key Takeaways
October 26, 2026
Every year, leading myeloma researchers and advocates from around the world gather…
Defining Cure in Multiple Myeloma
October 26, 2026
Since it was first described in 1844, multiple myeloma has largely been…
September: A Time to Walk, Connect, and Be Heard!
September 23, 2026
September is Blood Cancer Awareness Month, a time to recognize everyone affected by…
Building Credibility and Amplifying the Patient Voice
August 19, 2026
At Myeloma Canada, we often speak about the importance of ensuring that…
Key Takeaways from the Global Myeloma Action Network (GMAN) Summit
July 23, 2026
By Michelle Oana, Chief Mission Officer, Myeloma Canada Myeloma Canada was honoured to participate in the…
The Patient Voice: Measuring What Truly Matters
June 18, 2026
When we talk about progress in myeloma, we often focus on the…
Updating Quality of Life Measures in Multiple Myeloma
June 18, 2026
People with multiple myeloma are living longer. As treatments become more effective,…
Everything You Need to Know About Clinical Trials in One Place
May 21, 2026
May 20 is Clinical Trials Day, a global moment to recognize the…
Myeloma Canada’s 2025 Aldo Del Col Research Grant: Four Projects Advancing Myeloma Treatment
April 16, 2026
The Aldo Del Col Research Grant is Myeloma Canada’s flagship research funding…
Our Takeaways from ASH 2025: Real Progress and Growing Momentum in Myeloma Research
January 22, 2026
Myeloma Canada representatives joined thousands from the global hematology community at the…
Investing in the future of Canadian myeloma research: The impact of the Dr Andrew R Belch MEET Grant
November 27, 2025
Since its launch in 2019, the Dr Andrew R Belch Myeloma Education…
The Promise … and the Waiting: A New Era in Myeloma Treatment
October 26, 2026
When I think about the impact of new myeloma treatments, one word…
September: A Time to Walk, Connect, and Be Heard!
September 23, 2026
September is Blood Cancer Awareness Month, a time to recognize everyone affected by…
Myeloma Canada’s Advocacy Handbook: Newly updated!
August 19, 2026
Myeloma Canada’s National Advocacy Committee is proud to announce the release of…
Building Credibility and Amplifying the Patient Voice
August 19, 2026
At Myeloma Canada, we often speak about the importance of ensuring that…
Key Takeaways from the Global Myeloma Action Network (GMAN) Summit
July 23, 2026
By Michelle Oana, Chief Mission Officer, Myeloma Canada Myeloma Canada was honoured to participate in the…
Taking It Step by Step: New Checklists for Transplant and the Road Ahead
July 23, 2026
Living with multiple myeloma can involve many decisions, treatments and life changes, but education…
Updating Quality of Life Measures in Multiple Myeloma
June 18, 2026
People with multiple myeloma are living longer. As treatments become more effective,…
Everything You Need to Know About Clinical Trials in One Place
May 21, 2026
May 20 is Clinical Trials Day, a global moment to recognize the…
The Continuous Work of Advocacy
May 20, 2026
From the day Myeloma Canada was founded in 2005, our co-founder Aldo Del…
Access to treatment updates
February 26, 2026
Rezurock now reimbursed in Ontario and BC! Rezurock (belumosudil) is a new treatment for chronic graft-versus-host disease (GVHD), a condition…
Myeloma Canada Welcomes Restart of pCPA Negotiations for Carvykti®
February 26, 2026
Myeloma Canada welcomes the news that negotiations between the pan‑Canadian Pharmaceutical Alliance…
Patient Perspectives, Access to Treatment, and Navigating Complex Systems: A Look Back on a Year of Advocacy
January 22, 2026
In 2025, Myeloma Canada continued to advocate for a healthcare system where…
The 2026 Multiple Myeloma March is Underway
September 24, 2026
From Newfoundland to British Columbia and everywhere in between, the 2026 Multiple Myeloma March…
September: A Time to Walk, Connect, and Be Heard!
September 23, 2026
September is Blood Cancer Awareness Month, a time to recognize everyone affected by…
Myeloma Canada Board of Directors Elects New Chair: Lorelei Dalrymple
August 19, 2026
This Spring, the Myeloma Canada Board of Directors elected Lorelei Dalrymple as Chair of…
Myeloma Canada’s Advocacy Handbook: Newly updated!
August 19, 2026
Myeloma Canada’s National Advocacy Committee is proud to announce the release of…
Building Credibility and Amplifying the Patient Voice
August 19, 2026
At Myeloma Canada, we often speak about the importance of ensuring that…
The Multiple Myeloma March Is Just Around the Corner. See you at the Starting Line!
July 23, 2026
Summer has a way of bringing people together. We gather around backyard…
The Patient Voice: Measuring What Truly Matters
June 18, 2026
When we talk about progress in myeloma, we often focus on the…
The Myeloma Canada Ride: A Record-Breaking Cycling Season
June 18, 2026
This year’s Myeloma Canada Ride was nothing short of extraordinary. From coast…
5 Tips to Boost Your Myeloma Canada Ride Fundraising
May 21, 2026
Fundraising doesn’t have to feel overwhelming. Whether you’re a first-time rider or a seasoned cyclist, these…
The Continuous Work of Advocacy
May 20, 2026
From the day Myeloma Canada was founded in 2005, our co-founder Aldo Del…
Announcing the 2026 Marion State Memorial Nursing Award Recipient: Nina Mason
May 8, 2026
Myeloma Canada is proud to announce Nina Mason as the recipient of…
Announcing the Myeloma Canada Community Award Recipients
April 16, 2026
The Myeloma Canada community awards honour the outstanding achievements of individuals within…